Happy New Year's fellow longs. It's been awfully quiet here and at RGBP. We know they left off with news of their continued progress, so the assumption is that positive developments continue in 2018. Each testing step is iterative and leads to more and more concrete evidence that you have a cancer and/or autoimmune busting product. Which leads to funding, partnerships, buyouts. We have been told they are in the zone. Patiently waiting. IMO. GL.
News 
Market Data 
Discover 
